This study is designed to loook at the affect of oral SB-705498 on cough following an inhaled capsaicin challenge
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pharmacokinetic parameter of area under the plasma concentration-time curve from time zero to 4 hours AUC(0-4) and from time zero (pre-dose) to last time of quantifiable concentration AUC(0-t)- Part A
Timeframe: pre-dose, 0.5, 1, 1.5, 2, 3, 4, 6, 8 and 10 hours post-dose
Maximum observed concentration (Cmax) following 10 hour sampling of a single dose of SB-705498 - Part A
Timeframe: pre-dose, 0.5, 1, 1.5, 2, 3, 4, 6, 8 and 10 hours post-dose Day 1
Time of occurrence of Cmax (Tmax) following 10 hour sampling of a single dose of SB-705498 -Part A
Timeframe: pre-dose, 0.5, 1, 1.5, 2, 3, 4, 6, 8 and 10 hours post-dose
Capsaicin concentration required to achieve Five or more coughs (C5) following a single dose of SB-705498 at Tmax as compared to baseline- Part A
Timeframe: Day -1 (baseline) and Day 1 (2 hours post dose
Capsaicin concentration required to achieve C5 following a single dose of SB-705498 or placebo- Part B
Timeframe: Day -1, Day 1 (2hrs and 24 hrs post dose)
Cough Count Per 24 hour following single dose of SB-705498 as compared to placebo- Part B
Timeframe: Day -1 and Day 1 (2 and 24 hours)